LLY

1,098.63

-3.51%↓

JNJ

227.95

-1.23%↓

ABBV

217.5

-0.26%↓

UNH

380.35

-1.52%↓

MRK

118.68

-1.44%↓

LLY

1,098.63

-3.51%↓

JNJ

227.95

-1.23%↓

ABBV

217.5

-0.26%↓

UNH

380.35

-1.52%↓

MRK

118.68

-1.44%↓

LLY

1,098.63

-3.51%↓

JNJ

227.95

-1.23%↓

ABBV

217.5

-0.26%↓

UNH

380.35

-1.52%↓

MRK

118.68

-1.44%↓

LLY

1,098.63

-3.51%↓

JNJ

227.95

-1.23%↓

ABBV

217.5

-0.26%↓

UNH

380.35

-1.52%↓

MRK

118.68

-1.44%↓

LLY

1,098.63

-3.51%↓

JNJ

227.95

-1.23%↓

ABBV

217.5

-0.26%↓

UNH

380.35

-1.52%↓

MRK

118.68

-1.44%↓

Search

Quidel Corp

Open

13.04 -1.73

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

12.83

Max

13.53

Schlüsselkennzahlen

By Trading Economics

Einkommen

39M

-92M

Verkäufe

-104M

620M

Gewinnspanne

-14.811

Angestellte

6,500

Empfehlungen

By TipRanks

Empfehlungen

Neutral

12-Monats-Prognose

-2.43% downside

Dividenden

By Dow Jones

Nächstes Ergebnis

4. Aug. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-12M

688M

Vorheriger Eröffnungskurs

14.77

Vorheriger Schlusskurs

13.04

Quidel Corp Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

28. Mai 2026, 22:47 UTC

Ergebnisse

Costco 3Q Sales Rise as Value Offerings Draw Pressured Consumers -- Update

28. Mai 2026, 20:45 UTC

Ergebnisse

Costco 3Q Profit Rises as Value Offerings Draw Pressured Consumers

28. Mai 2026, 23:43 UTC

Market Talk

Nikkei May Rise on Hopes for U.S.-Iran Peace Deal -- Market Talk

28. Mai 2026, 23:39 UTC

Market Talk

Gold Edges Lower as Traders Assess Potential U.S.-Iran Deal -- Market Talk

28. Mai 2026, 23:31 UTC

Market Talk

KMD Could Realize Value From Selling Either Oboz or Rip Curl -- Market Talk

28. Mai 2026, 23:17 UTC

Market Talk

Mainfreight Steering Its Way Out of Tough Period -- Market Talk

28. Mai 2026, 23:02 UTC

Market Talk

Costco Has Started Submitting Tariff Refund Claims -- Market Talk

28. Mai 2026, 22:41 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

28. Mai 2026, 22:41 UTC

Market Talk

MongoDB Still Getting More Growth From Established Customers Than AI -- Market Talk

28. Mai 2026, 22:37 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

M&A-Related Insurance Payments In North America Rise -- Market Talk

28. Mai 2026, 22:04 UTC

Akquisitionen, Fusionen, Übernahmen

CN: Surface Transportation Board Was Right to Freeze the UP-NS Merger and Demand More Info

28. Mai 2026, 22:04 UTC

Akquisitionen, Fusionen, Übernahmen

CN: This Confirms What CN and Many Stakeholders Have Said All Along, UP and NS Still Have Not Submitted a Credible Case to Support Their Proposed Merger >CNI

28. Mai 2026, 21:12 UTC

Ergebnisse
Akquisitionen, Fusionen, Übernahmen

Synopsys Was the Worst S&P 500 Stock Thursday Despite Earnings Beat With AI and Merger in Focus -- Barrons.com

28. Mai 2026, 21:00 UTC

Ergebnisse

Dell Stock Soars on Blowout Earnings. The Outlook Bests Analysts by $20 Billion. -- Barrons.com

28. Mai 2026, 20:57 UTC

Ergebnisse

Dell Stock Soars on Blowout Earnings -- Barrons.com

28. Mai 2026, 20:55 UTC

Ergebnisse

Costco Wholesale Sees a Mixed Quarter, Misses Earnings Estimates -- Barrons.com

28. Mai 2026, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

28. Mai 2026, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

28. Mai 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

28. Mai 2026, 20:48 UTC

Heiße Aktien

Stocks to Watch Recap: Snowflake, Union Pacific, Hormel Foods -- WSJ

28. Mai 2026, 20:34 UTC

Ergebnisse

One of the S&P 500's Highest Dividends Looks Even Better Now -- Barrons.com

28. Mai 2026, 20:31 UTC

Ergebnisse

Li and XPeng Both Miss Earnings Estimates. One Chinese EV Maker's Stock Is Rising. -- Barrons.com

28. Mai 2026, 20:28 UTC

Ergebnisse

Best Buy's 5% Dividend Yield Looks Even Better After Earnings -- Barrons.com

28. Mai 2026, 20:26 UTC

Ergebnisse

Dell Stock Soars on Blowout Earnings -- Barrons.com

28. Mai 2026, 20:20 UTC

Ergebnisse

Costco 3Q Membership Fees $1.37B

28. Mai 2026, 20:20 UTC

Ergebnisse

Costco 3Q Net Sales $69.15B

28. Mai 2026, 20:19 UTC

Ergebnisse

Costco 3Q Adj Same-Store Sales, Which Excludes Impacts From Gas Prices and Foreign Exchange, Rose 6.6% >COST

28. Mai 2026, 20:19 UTC

Ergebnisse

Costco 3Q Adjusted Digitally-Enabled Sales Rose 20.8% >COST

28. Mai 2026, 20:17 UTC

Ergebnisse

Costco 3Q Digitally-Enabled Sales Rose 21.5% >COST

28. Mai 2026, 20:17 UTC

Ergebnisse

Costco 3Q Same-Store Sales Up 9.8% >COST

Peer-Vergleich

Kursveränderung

Quidel Corp Prognose

Kursziel

By TipRanks

-2.43% Nachteil

12-Monats-Prognose

Durchschnitt 12.03 USD  -2.43%

Hoch 13 USD

Tief 11 USD

Basierend auf 6 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Quidel Corp – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

6 ratings

1

Buy

4

Halten

1

Sell

Finanzen

Vertriebs- und Verwaltungskosten

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

Betriebsergebnis

$

Über Quidel Corp

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California.
help-icon Live chat